Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation.
Eleanor Bimla Schwarz, Carrie A Lewis, Melanie S Dove...
https://pubmed.ncbi.nlm.nih.gov/35194746/Actively Recruiting
Led by University of California, San Francisco · Updated on 2026-01-26
650
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating whether providing women who strongly want to avoid future pregnancy with detailed information comparing tubal sterilization to long-acting reversible contraceptives LARC improves their perceived access to different contraceptive options. The study aims to support patient-centered contraceptive care by increasing knowledge and access to all long-acting contraceptives. This research also seeks to reduce the number of women who regret permanent sterilization and address racial disparities in surgical sterilization. Participants are randomly assigned to one of two groups one group accesses a new website that compares tubal sterilization and LARC based on recent patient-centered outcomes research, while the other group views an existing Planned Parenthood webpage focused on tubal sterilization. These web-based resources serve as educational interventions to help patients prepare for discussions with their healthcare providers about contraception. During the study, participants complete a baseline survey, explore their assigned website, and then complete a brief follow-up survey immediately afterward. They also complete another follow-up survey three months later. Researchers measure outcomes such as perceived access to long-acting contraceptives, contraceptive counseling quality, patient-provider interactions, knowledge about contraceptive methods, use of preferred contraception, and willingness to recommend the website. The study includes safety and adherence monitoring through surveys and lasts at least three months from enrollment.
CONDITIONS
Patient-centered Information on Permanent Contraception
E
Eleanor Schwarz, MD, MS
A
Agatha Okobi
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, San Francisco
Lead Sponsor
Essential Access Health
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Patient-centered contraceptive comparison website | Standard information website on tubal sterilization |
|---|---|---|
| What it is | An interactive, patient-centered website that presents information comparing tubal sterilization with long-acting reversible contraceptives, including intrauterine devices and implants. The website is designed to support informed reproductive decision-making. | A standard educational website providing information about tubal sterilization, based on resources currently offered on the Planned Parenthood platform. It does not include comparative content on long-acting reversible contraceptives. |
| Role in the trial | Participants access the Advancing Access Website as the main intervention and receive information designed to support informed choices between permanent and long-acting contraceptive options. | Participants access the standard information website, which serves as the control arm by presenting only current information on tubal sterilization. |
| Primary use | Designed to improve knowledge about, and access to, various permanent and long-acting contraception options, supporting women in making informed reproductive choices. | Provides education about tubal sterilization for those considering permanent contraception, without information on alternative long-acting methods. |
| How it is given or performed | Participants access the interactive website online, reviewing patient-centered comparative content during the trial period. | Participants review the current Planned Parenthood website information on tubal sterilization online, without comparative content on other contraceptives. |
| Evidence status | This website is undergoing evaluation in a randomized clinical trial. Evidence of its impact on contraceptive decision-making and access is not yet established. | The standard website is widely available and currently used, but its specific comparative impact on knowledge or decision-making has not been systematically evaluated in this population. |
| Important limitations | Actual patient outcomes, such as method use or satisfaction with decision-making, have not yet been reported. Website accessibility or personal preferences may influence usefulness. | Does not provide information on long-acting reversible contraceptives, so participants may lack comparison between permanent and reversible options for contraception. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - Single session
Participants are introduced to one of two educational websites to provide information on tubal sterilization and long-acting reversible contraceptives to support contraceptive decision-making.
1 visit (online introduction to website)
Duration - 3 months
Participants complete follow-up assessments to evaluate perceived access, knowledge, counseling experience, contraceptive use, and satisfaction with the educational websites.
1 follow-up visit (online or remote) at 3 months
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Eleanor Bimla Schwarz, Carrie A Lewis, Melanie S Dove...
https://pubmed.ncbi.nlm.nih.gov/35194746/University of California, San Francisco
Lead Sponsor
Essential Access Health
Collaborating Sponsor